isradipine has been researched along with Depression, Endogenous in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pazzaglia, PJ | 1 |
| Post, RM | 1 |
| Ketter, TA | 1 |
| Callahan, AM | 1 |
| Marangell, LB | 1 |
| Frye, MA | 1 |
| George, MS | 1 |
| Kimbrell, TA | 1 |
| Leverich, GS | 1 |
| Cora-Locatelli, G | 1 |
| Luckenbaugh, D | 1 |
1 trial available for isradipine and Depression, Endogenous
| Article | Year |
|---|---|
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Depressive Disor | 1998 |